Tergio

Tergio (Teriflunomide) is an oral medication used to manage certain autoimmune conditions. This disease-modifying therapy helps reduce inflammation and immune system activity. Suitable for adults, it is prescribed under medical supervision for long-term symptom control. Commonly used for relapsing forms of multiple sclerosis.

Tergio (Teriflunomide) is primarily used to treat relapsing forms of multiple sclerosis (MS) in adults. It belongs to a class of medications known as immunomodulatory agents, which help reduce inflammation and slow disease progression. Patients often ask, 'what is Teriflunomide used for'—it is designed to decrease the frequency of relapses and delay physical disability. This medication may also be considered for other autoimmune-related conditions as determined by a healthcare provider.

Tergio (Teriflunomide) works by modulating the immune system to reduce inflammation in the central nervous system. Users may notice a decrease in the number and severity of MS relapses over time. Some individuals report improved mobility and reduced fatigue, though responses vary. Regular monitoring is recommended to assess its ongoing effectiveness and safety.

Tergio (Teriflunomide) should be taken exactly as prescribed by a healthcare professional. It is important to discuss your full medical history, including liver or kidney conditions, before starting treatment. Blood tests are typically required before and during therapy to monitor for potential side effects. Avoid pregnancy while taking this medication, as it may cause harm to an unborn child. Use effective contraception if you or your partner could become pregnant.

Tergio (Teriflunomide) may interact with other medications, including certain vaccines, blood thinners, and cholesterol-lowering drugs. Combining it with alcohol is not recommended, as it may increase the risk of liver-related side effects. Inform your doctor about all prescription, over-the-counter, and herbal products you are using. Live vaccines should be avoided during treatment due to potential reduced effectiveness.